CA48226-1 - 0x0000000000006733
Males & Females of Non-Childbearing Potential
Jewel
* Stipend may pay up to reflected amount.
Start Date:
July 8, 2025 - 5:30am
End Date:
August 23, 2025 - 11:30am
Study Details
Study Number: CA48226
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00
Study Criteria
Age: 19 - 55
BMI: 18.5 - 29.9
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat atrial fibrillation.
Route of Administration: Oral
Blood Draws: 50
Study Schedule
Schedule Type: Long Term
Study Length: 17 Night Stay & 1 Phone Call
Screening Dates:
Event Day | Event Date |
---|---|
Thursday | 6/26/2025 |
Friday | 6/27/2025 |
Tuesday | 7/1/2025 |
Wednesday | 7/2/2025 |
Thursday | 7/3/2025 |
Monday | 7/7/2025 |
Doctor Exam Dates:
Event Day | Event Date |
---|---|
Thursday | 6/26/2025 |
Friday | 6/27/2025 |
Tuesday | 7/1/2025 |
Wednesday | 7/2/2025 |
Thursday | 7/3/2025 |
Monday | 7/7/2025 |
Study Dates:
Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
---|---|---|---|---|---|---|
Check-In | Tuesday | 7/8/2025 5:30:00 AM | 7/25/2025 8:30:00 AM | 1 | Lincoln | |
Phone participant | Saturday | 8/23/2025 11:30:00 AM | 2 | Lincoln |